PROTIA Allergy-Q 128M (Allergy Diagnostic IVD Device)

PROTIA Allergy-Q 128M (Allergy Diagnostic IVD Device)

Detects allergen-specific IgE and quantifies total IgE in human serum or plasma (heparin/citrate anticoagulated) via immunoblotting, diagnosing over 1


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Brand name
PROTIA Allergy-Q
Payment Terms
L/C,T/T
Production method
Available
Shipping / Lead Time
Negotiable / Negotiable
Keyword
allergy, diagnosic kits, mast
Category
Medical Devices

Proteometech Co., Ltd.

Membership
PRO
Country / Year Established
South Korea South Korea / 2000
Business type
Manufacturer
Verified Certificate

10

DUNS

Product name PROTIA Allergy-Q 128M (Allergy Diagnostic IVD Device) Certification -
Category Medical Devices Material -
Keyword allergy , diagnosic kits , mast Unit Size -
Brand name PROTIA Allergy-Q Unit Weigh -
origin South Korea Stock 20
Supply type Available HS code 3822

Product Information

PROTIA Allergy-Q 128M is a cutting-edge multiplex diagnostic kit designed to detect and evaluate 117 specific allergens, including total IgE, in a single test. This innovative solution provides a reliable and efficient method for diagnosing atopic allergy, a hypersensitive immunological condition mediated by immunoglobulin E (IgE) antibodies. Allergens stimulate lymphocyte B cells to produce IgE, which binds to mast cells or basophilic leukocytes. Upon re-exposure to the allergen, this triggers cell degranulation, releasing vasoactive amines that cause symptoms such as hay fever, asthma, dermatitis, hives, and anaphylactic shock. Assessing IgE levels is essential for precise diagnosis and effective management of these conditions.

 

The PROTIA Allergy-Q 128M uses enzyme immunoassay principles, incorporating nitrocellulose membranes with allergens adsorbed at regular intervals. These membranes are organized into a single plastic panel, enabling simultaneous testing of dozens of allergens. Allergen-specific IgE antibodies bind to antigens on the membrane, followed by binding to biotin-coupled anti-human IgE antibodies. The biotin is captured by streptavidin conjugated with alkaline phosphatase, and a substrate reaction produces a color gradient from light purple to dark purple. This color intensity, proportional to IgE concentration, is analyzed using a precise color-measuring device.

With its ability to process a wide range of allergens in one test, PROTIA Allergy-Q 128M provides an advanced, comprehensive, and user-friendly approach to allergy diagnosis.

Key Features of PROTIA Allergy-Q 128M

  • Comprehensive Allergen Detection: Detects 117 specific allergens and total IgE in a single test.
  • Efficient Multiplex Testing: Features four nitrocellulose membranes on a single panel, enabling simultaneous evaluation of multiple allergens.
  • Accurate IgE Quantification: Based on enzyme immunoassay (EIA) principles, ensuring precise and reliable measurement of allergen-specific IgE.
  • Color-Based Quantitative Analysis: Produces a gradient color change from light purple to dark purple proportional to IgE concentration, analyzed using a color-measuring device.
  • User-Friendly and Reliable: Provides comprehensive allergy information in one test, streamlining the diagnostic process.
  • Supports Diagnosis of Various Clinical Symptoms: Suitable for assessing conditions such as hay fever, asthma, dermatitis, hives, and anaphylactic shock.
  • Advanced Technology: Utilizes streptavidin-alkaline phosphatase and biological reactions for high sensitivity and specificity.

 

B2B Trade

Price (FOB) Negotiable transportation Negotiation Other
MOQ Negotiable Leadtime Negotiable
Payment Options L/C,T/T Shipping time Negotiable

Proteometech Co., Ltd.

Country / Year Established
South Korea South Korea / 2000
Membership
PRO
Business type
Manufacturer

10

DUNS

President
SooYeon Lim
Address
yangcheon-ro A-702&813&1103&1104, Gangseo-gu, Seoul, Korea
Product Category
Facial Care,Skin Care Set
Year Established
2000
No. of Total Employees
51-100
Company introduction

 

 

"Happiness for Myself, the Company, and Society!"
Protia is dedicated to creating a healthy and happy society with cutting-edge diagnostic technology. As a prominent name in K-Bio, Protia aspires to become a global leader in in vitro diagnostics (IVD).

Protia Co., Ltd. is an in vitro diagnostics company at the forefront of advancements that improve quality of life and extend life expectancy. Our unique technologies set us apart, including parallel-line multiplex diagnostic technology, multi-test line immunochromatography, capacitive sensor technology, and biomarker development.

"Happiness for Myself, the Company, and Society!"
Protia is committed to rising as a world-renowned in vitro diagnostics specialist, building a happier, healthier future for all.

Main Markets

South Korea South Korea

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more